June 22, 2020
UC San Diego researchers uncovered in mice how IRE1α, a molecule involved in cells’ response to stress, determines whether macrophages promote inflammation in the tumor microenvironment. Inflammation is known to promote tumor growth, making IRE1α an attractive target for drug development.
May 21, 2024
Current methods to model or correct mutations in live cells are inefficient, especially when multiplexing — installing multiple point mutations simultaneously across the genome. Researchers from the UC San Diego have developed new, efficient genome editing tools called multiplexed orthogonal base editors (MOBEs) to install multiple point mutations at once.…
January 9, 2012
The new UC San Diego-Roche Extending Innovation Network (EIN) program has been launched with selection of its first three research projects at the University of California, San Diego School of Medicine.
April 12, 2016
To rally the San Diego region in the fight against cancer, the University of California San Diego’s Moores Cancer Center will host its annual SPARK Gala on Saturday, April 16 at the Fairmont Grand Del Mar. The evening will include a three-course dinner with wine pairings, a live luxury auction…
October 22, 2020
UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer. Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
May 4, 2016
Researchers at University of California San Diego School of Medicine have demonstrated that distinct types of glioblastoma, the most common form of brain cancer in adults, tend to develop in different regions of the brain. This finding provides an explanation for how the same cancer-causing mutation can give rise to…
January 18, 2024
Cancer resists treatment in a multitude of ways, but a new algorithm developed by scientists at UC San Diego can decode them all simultaneously.
March 17, 2021
By studying how different pluripotent stem cell lines build muscle, researchers have for the first time discovered how epigenetic mechanisms can be triggered to accelerate muscle cell growth, providing new insights for developing therapies for muscle disease, injury and atrophy.
October 16, 2014
…need them. Together, with generous donors like Carol, we are creating a healthier world, one patient at a time.” “We express our sincere gratitude to Carol for this transformative gift to UC San Diego,” said David Brenner, MD, Vice Chancellor for Health Sciences and Dean of the UC San Diego…
May 4, 2023
Chemistry professor Alexis Komor’s lab designed the Genome Editing Technologies Program as a way to educate high school students on gene-editing technologies and expose them to a possible career in STEM.
